Immunotherapy & Targeted Therapy
Precision medicine that harnesses your body's defences and targets cancer at the molecular level.
Years Experience
Molecular Testing
Global Protocols
Understanding Precision Cancer Treatment
Immunotherapy and targeted therapy represent the forefront of cancer medicine. Unlike traditional chemotherapy that affects all rapidly dividing cells, these treatments are designed to specifically attack cancer while sparing healthy tissue. At Jain Oncology, we use comprehensive molecular profiling to match you with the most effective precision therapy available.
Immunotherapy Approaches
Harnessing your body's immune system to recognise and destroy cancer cells.
Checkpoint Inhibitors
Drugs like Pembrolizumab and Nivolumab that release the 'brakes' on your immune system, allowing T-cells to attack cancer.
Monoclonal Antibodies
Lab-made antibodies that target specific proteins on cancer cells, marking them for immune destruction.
CAR T-Cell Therapy
Your own T-cells are modified in a lab to better recognise and attack cancer cells — a breakthrough for certain blood cancers.
Cancer Vaccines
Stimulate the immune system to recognise and attack specific cancer-associated antigens.
Targeted Therapy Types
Precision drugs that attack specific molecules driving cancer growth.
Tyrosine Kinase Inhibitors (TKIs)
Block specific enzymes that drive cancer growth — used in lung, kidney, liver, and other cancers.
HER2-Targeted Therapy
Trastuzumab and similar drugs for HER2-positive breast and gastric cancers.
PARP Inhibitors
Exploit DNA repair defects in BRCA-mutated cancers, particularly ovarian and breast cancers.
Anti-Angiogenesis Agents
Block new blood vessel formation that tumours need to grow and spread.
Antibody-Drug Conjugates
Smart missiles that deliver chemotherapy directly to cancer cells via targeted antibodies.
CDK4/6 Inhibitors
Block cell cycle proteins in hormone receptor-positive breast cancer, significantly improving outcomes.
Biomarker Testing
- PD-L1 expression testing for immunotherapy eligibility
- Microsatellite instability (MSI) and mismatch repair (MMR) testing
- Tumour mutational burden (TMB) analysis
- Next-generation sequencing (NGS) for actionable mutations
- HER2, EGFR, ALK, ROS1, BRAF, and other targetable markers
- Liquid biopsy for non-invasive molecular profiling
Why Choose Jain Oncology
- Comprehensive molecular profiling for every patient
- Access to the latest immunotherapy and targeted drugs
- Multidisciplinary tumour board discussions
- Close monitoring for immune-related side effects
- Coordination with global oncology centres
- Affordable precision medicine in India
Frequently Asked Questions
Explore Precision Treatment Options
Find out if immunotherapy or targeted therapy is right for your cancer with a comprehensive molecular evaluation.